CECIL BENNETT: Open Payments
NPI 1982773610 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 17 payments from 12 companies in 2025. Trend: 2023 $451 · 2024 $562 · 2025 $336
Food & beverage: $308Entertainment: $28
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Optos, Inc. | 2 | $28 |
| Exact Sciences Corporation | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ozempic, JARDIANCE, REXULTI, AZMIRO, NFC-700, Cologuard Collection Kit, SPRAVATO, OPSUMIT.
Industry payments across GA — which companies pay providers there.
